Zhongquan Sun
- Biomaterials top 5%
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 6
- Biomedical Engineering top 10%
-
- Prostate Cancer Treatment and Research 10
- Renal cell carcinoma treatment 4
-
- Bladder and Urothelial Cancer Treatments 8
- Urinary and Genital Oncology Studies 5
- Cholangiocarcinoma and Gallbladder Cancer Studies 4
-
- RNA modifications and cancer 7
-
- Radiopharmaceutical Chemistry and Applications 6
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Zhongquan Sun
63 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Biomaterials 203
- Cancer Research 191
- Biomedical Engineering 460
- Pulmonary and Respiratory Medicine 213
- Materials Chemistry 295
Countries citing papers authored by Zhongquan Sun
This map shows the geographic impact of Zhongquan Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongquan Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongquan Sun more than expected).
Fields of papers citing papers by Zhongquan Sun
This network shows the impact of papers produced by Zhongquan Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongquan Sun. The network helps show where Zhongquan Sun may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhongquan Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 8 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 18 | |
| 7 | 2023 | 4 | |
| 8 | 2022 | 10 | |
| 9 | 2022 | 33 | |
| 10 | 2022 | 2 | |
| 11 | 2021 | 15 | |
| 12 | 2020 | 14 | |
| 13 | 2020 | 9 | |
| 14 | 2020 | 93 | |
| 15 | 2019 | 17 | |
| 16 | 2018 | 1 | |
| 17 | 2016 | 13 | |
| 18 | 2016 | 41 | |
| 19 | 2015 | 11 | |
| 20 | 2015 | 2 |
About Zhongquan Sun
Zhongquan Sun is a scholar working on Hepatology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 64 papers that have together received 1.3k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (10 papers), Bladder and Urothelial Cancer Treatments (8 papers), RNA modifications and cancer (7 papers), Radiopharmaceutical Chemistry and Applications (6 papers), Cancer-related molecular mechanisms research (6 papers), Urinary and Genital Oncology Studies (5 papers), Renal cell carcinoma treatment (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). The work is most often cited by research in Biomaterials (203 citations), Cancer Research (191 citations) and Biomedical Engineering (460 citations). Zhongquan Sun has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Weilin Wang, Yuan Ding, Zhengwei Mao, Zongrui Tong, Sitong Zhang, Qianhui Xu, Liuzhi Zhou, Sheng Yan, Binglin Ye and Jiaojiao Zhang.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.